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Abstract
Background: Efficient dissection of large proteins into their structural domains is critical for high throughput
proteome analysis. So far, no study has focused on mathematically modeling a protein dissection protocol in terms
of a production system. Here, we report a mathematical model for empirically optimizing the cost of large-scale
domain production in proteomics research.
Results: The model computes the expected number of successfully producing soluble domains, using a
conditional probability between domain and boundary identification. Typical values for the model’s parameters
were estimated using the experimental results for identifying soluble domains from the 2,032 Kazusa HUGE protein
sequences. Among the 215 fragments corresponding to the 24 domains that were expressed correctly, 111,
corresponding to 18 domains, were soluble. Our model indicates that, under the conditions used in our pilot
experiment, the probability of correctly predicting the existence of a domain was 81% (175/215) and that of
predicting its boundary was 63% (111/175). Under these conditions, the most cost/effort-effective production of
soluble domains was to prepare one to seven fragments per predicted domain.
Conclusions: Our mathematical modeling of protein dissection protocols indicates that the optimum number of
fragments tested per domain is actually much smaller than expected a priori. The application range of our model is
not limited to protein dissection, and it can be utilized for designing various large-scale mutational analyses or
screening libraries.
Background
Comprehensive elucidation of the functional and struc-
tural units present in the proteome is the ultimate goal
in proteomics research, and it is expected to provide
b a s i cd a t af o rar a t i o n a lu n d e r s t a n d i n go fc o m p l e xb i o -
logical systems. As proteomics studies are being pursued
[1-5], the development of efficient methodologies for
dissecting long protein sequences into their domains is
becoming critical. This is because biologically important
proteins are often large and are thus difficult to express,
purify and characterize in a high throughput manner [6].
Experimental approaches for dissecting proteins are
usually based on limited proteolysis, which has been
used to explore protein domain boundaries [7].
Although experimental protein dissection methods have
been extended to high throughput protocols [8-10], they
remain essentially expensive and time-consuming.
Computer-aided protein dissection approaches are
relatively inexpensive, and thus represent promising
methodologies that have practical values in high
throughput proteomics research. The strategies for pre-
dicting novel domain regions, without sequence similar-
ity to domain databases, can be categorized into two
classes. The first strategy aims at directly predicting
domain regions by analyzing various sequence properties
of the foldable region (e.g., see Refs [11,12]). The second
strategy is to first predict the location of the domain
boundaries and then use this information to infer the
domain’s position (e.g., see Refs [13,14]). Both strategies
are essential to efficiently identify novel protein
domains.
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ble and well behaved proteins enabling a fast structural/
functional analysis [15]. Solubility is an important criter-
ion strongly reflecting a protein’s suitability for biophysi-
cal characterization. It can be readily monitored, and
solubility assays are thus applied to large-scale studies
[16]. Furthermore, when solubility is used to assess
domain dissection experiments, it appears that a large
fraction of soluble fragments are indeed well folded as
assessed by NMR [17,18].
So far, reports of high throughput protein domain
production protocols have mainly focused on their
development and on optimizing individual experimental
steps of the protocols. No study has mathematically
modelled a protein domain production protocol in
terms of a production system, and thus substantial
room for cost-optimization through mathematical mod-
eling remains available. In this report, we present a
mathematical model for empirically optimizing large-
scale protein domain production. Our model concep-
tually divides domain predictions into the prediction of
the domain region and its boundary, and it computes
the expected number of successfully produced soluble
domains, using a conditional probability between these
two events. We estimated the model parameters using
the experimental results from a computer-aided
identification of novel soluble protein domains from
Kazusa HUGE protein sequences, in which 436 frag-
ments, encoding 36 novel putative domains with slightly
different domain boundaries, were expressed by using
an E-coli-based cell-free system, and their solubilities
were assessed with SDS-PAGE gels.
Results and Discussion
Mathematical model of protein dissection
In our mathematical model, the prediction of a protein
domain is conceptually divided into two steps: A first
step that predicts the existence of a domain, and a sec-
ond step that predicts its boundaries (or termini). “Frag-
ments” are domain fragments with specific termini
residues, and each fragment is either soluble or insolu-
ble. Soluble fragments and insoluble fragments belong
to the soluble (S) and insoluble set (S
c), respectively
(Figure 1a). S and S
c are mutually exclusive sets, and S
c
is the complement of S. We define a “soluble domain”
as a domain that encodes at least one soluble fragment.
A fragment that is associated with a “soluble domain” is
an element of the set D (Figure 1b). According to this
definition, some fragments encoding a soluble domain
may be insoluble. The fragments encoding non-soluble
domains, i.e., predicted domains for which all fragments
are insoluble, are elements of the set D
c (Figure 1b and
Figure 1 Sets for our model. An element of the sets in our model is an experimentally expressed protein domain fragment. (a) All elements
are either soluble (S) or insoluble (S
C) fragments. (b) Alternatively, each fragment belongs to either a soluble domain (D) or a non soluble
domain (D
C). (c) The whole set can be decomposed into four exclusive subsets: D ∩ S (white area); D ∩ S
C (lines on light grey area); D
C ∩ S
C
(lines on dark grey area); and D
C ∩ S (not shown, since it is empty). (d) An example of the elements in the D subset. Fragments from a soluble
domain (domain1) are shown. They can be classified into either the D ∩ So rD∩ S
C subset (e) Fragments from a non soluble domain (domain
2) are shown. All elements belong to D
C ∩ S.
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Page 2 of 91e). Practically, a domain is defined as non-soluble if all
of the tested fragments associated with a given domain
(in our experiment, 9 per domain, on average) are inso-
luble. D and D
c are also mutually exclusive sets, and
their elements are fragments (not domains). The above
classification yields four fragment categories (Figure 1c):
S ∩ D (Soluble domain fragments with correct N and C
termini), S
c ∩ D (Insoluble fragments encoding a soluble
domain, presumably because of incorrect termini), S ∩
D
c (Soluble fragment encoding a non-domain or a failed
domain prediction; this set is obviously empty), and S
c ∩
D
c (Insoluble fragment encoding a non-domain; all ele-
ments of D
c obviously belong to S
c).
The probability of successfully predicting a soluble
fragment, p(S), is expressed as
pp p SS D S D S D
c          , (1)
since S ∩ D
c is empty and all sets are exclusive. p(D)
is thus related to p(S) as
pp p p SS DD S D        |, (2)
where p(S|D) is the conditional probability of obtain-
ing a soluble fragment of a soluble domain. When p(S)
and p(S|D) are given, the probability of successfully pre-
dicting the existence of a soluble domain is calculated as
p
p
p
p
p
()
()
(| )
()
(| )
. D
SD
SD
S
SD


 (3)
Note that Eqs. 1-3 are direct consequences from prob-
ability rules for independent sets, without any approxi-
mations or assumptions.
In a large-scale experiment aimed at obtaining as
many soluble domains as possible, cost-optimization is
achieved by maximizing the number of soluble domains
for a fixed number of tests. As an approximation, our
model computes the expected number of producing
soluble domains, Edomain, by assuming average probabil-
ity values over all of the protein domains examined in
the experiment. Our model examines M protein
domains and generates N fragments per domain.
According to this model, the expected number of solu-
ble domains, Edomain, is given by:
EM p P
constant
N
pP N p S D NN domain DD     () (, | ) ,(4)
where M and N are, respectively, the number of
domains and the number of fragments per domain that
are assessed. When the total number of fragments (MN)
is held constant, the probability of obtaining one or
more soluble fragments, PN, is a function of N and p(S|
D). The explicit form of PN depends on the experimen-
tal setting, and is derived in the next section for two
specific cases.
We can further modify Eq. 4 to add a set-up cost
related to the analysis of a new domain. The set-up cost
is taken into account by expressing the total cost as MN
+ Mr,w h e r er is the ratio between the supplemental
cost of analyzing a fragment from a new domain and
that of analyzing a new fragment from the current
domain. Keeping the total cost constant [M (N + r)=
constant] yields:
E
constant
Nr
pP N p S D N domain D 
  () (, | ) . (5)
Derivation of PN for two basic experimental settings
Let us derive PN for two basic types of experimental set-
tings. In the first one, the generation of N fragments
occurs by independent events (multiple copy case). This
situation occurs in genetic screening experiments, where
N fragments per domain are randomly selected and
tested, allowing multiple copies of the same fragment to
be tested. In this case, the mathematical expression for
PN is simply calculated as:
Pp p
f
F
N
N N
N
      




 11 11 1 S| D S | D
c , (6)
where PN is the probability of obtaining one or more
s o l u b l ef r a g m e n t so fas o l u b l ed o m a i nw h e nN frag-
ments are simultaneously tested. F is the (average) num-
ber of all of the testable (assessable) fragments, and f is
the (average) number of soluble fragments associated to
a domain.
The second situation occurs when N fragments are
generated, but each fragment is selected only once (single
copy case). This situation occurs when the fragments are
identifiable, such as in our pilot experiment with the
Kazusa sequences. PN i sd e r i v e db yu s i n gah y p e r g e o -
metric distribution (PN
C), which describes the probability
of obtaining no soluble elements when N elements are
drawn without replacement from a finite population of
FCN elements (mCn indicates the binomial coefficient for
choosing n elements from m elements). PN is given by
PP Ff CN
F CN
Ff FN
FfN F
NN
C   
   
 
11 1
!!
!!
, (7)
where PN
C is the probability of obtaining no soluble
fragments when N fragments are tested (see Additional
file 1 for detail.) A JavaScript program, implementing
Eqs. 5-7, is available in Additional file 2.
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Page 3 of 9Parameter estimation from a pilot experiment with
Kazusa HUGE domains
The application range of our mathematical model is not
restricted to describe or analyze a specific domain pre-
diction method (such as Armadillo[19], or PRODOM
[20]), or experimental procedure (E-coli strains, or cell
free systems). The specific settings/protocols are taken
into account by adjusting or optimizing the values of
the model’s parameters. Here, we will estimate typical
values for the parameters using the solubility of protein
domains predicted in the Kazusa HUGE protein
sequences [21].
We first identified 36 putative domains using Proteo-
Mix [22] (Figure 2a), and for each domain, we expressed
several fragments with different N and/or C-terminal
residues distributed over the predicted termini window
(Figure 2b). This yielded a total of 436 fragments;
namely, 12 fragments per domain were generated, on
average, to probe the domain termini. Among the 436
fragments, 215 (corresponding to 24 domains) were
expressed correctly and were eventually assessed (Addi-
tional file 3); 111 fragments (encoding 18 domains) were
soluble, and 104 fragments (encoding 6 domains) were
insoluble (Figure 3).
For the purpose of discussion, let us estimate the para-
meters using the 215 fragments corresponding to the 24
domains that expressed correctly. Among these
Figure 2 Design of domain fragments. (a) Snap shot of the ProteoMix for the Kazusa HUGE KIAA1131 sequence. The results of PASS (domain
predictions, Domain), DLiP and DLP (domain linker predictions, Linker), HMMTOP and MEMSAT (transmembrane predictions, Transmembrane),
and BLAST to PDB sequences (homology to structurally known sequences, Blast_to_PDB) are shown. (b) Domain fragment design scheme. For
each dissected domain, the corresponding linker or the N- or C-terminus of the full-length sequence that is in the N- or C-terminal end of the
domain is used to determine the termini of the fragments. Three cleavage sites are defined along the linker region. The first one is at the end of
the predicted linker on the PASS-predicted domain side (cleavage site 1), the second one is located in the middle of the linker region (cleavage
site 2), and the third one is at the end of the linker region, opposite from the domain side (cleavage site 3). In addition, we designed a cleavage
site at the terminal ends of the PASS-predicted domain (cleavage site 0) and at either the N or C terminus of the protein (cleavage site 4, in
case it was close to the C- or N- terminus of the domain). Some cleavage sites were not defined: for example, when the length of a linker was
too short to determine its center, the central cleavage site was omitted. The number of generated fragments was regarded as sufficient for
assessing the presence of a cleavable site and for estimating the model’s parameters.
Figure 3 Summary of the solubility experiment.S o l u b l e
(SOLUBLE), insoluble (INSOLUBLE), and not applicable (N/A) domains
(left bar) and the corresponding fragments (right bar) are shown. N/
A includes all kinds of experimental incompleteness, such as
insufficient PCR, wrong cDNA sequences, no expression or
ambiguous SDS-PAGE results.
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Page 4 of 9domains, 75% (18/24), and 52% (111/215; which corre-
sponds to p(S) and p(S
C)=0 . 4 8 ;T a b l e1 )o ft h ef r a g -
ments were soluble when 9 fragments were tested on
average (instead of 12 when all 436 of the fragments are
considered). p(S|D), which is the conditional probability
of correctly predicting a soluble fragment of a soluble
domain, is 0.63 (111 fragments/175 fragments). The cal-
culation of p(D) from Eq. 3, using the obtained values of
p(S) and p(S|D), generates 0.81. Substituting 0.81 and 9
for p(D) and N, respectively, in Eq. 4, yields Edomain/M
as 0.81, which is equal to p(D), within rounding error,
since PN is almost 1 when N = 9. The discrepancy from
t h ea b o v ee x p e r i m e n t a lEdomain/M value of 0.75 (Figure
3), is due to the use of average values. Indeed, for 6
domains, all of the fragments were soluble, and 12
domains yielded a mixture of soluble and insoluble frag-
ments (Figure 4a). However, the corrections appear to
be modest (less than 10%) and will not significantly
affect the following discussion (the calculation with
non-averaged f and F values is discussed in Additional
file 1).
Let us perform a simple mathematical simulation to
assess the discrepancy between the above experimental
and calculated values of 0.75 and 0.81. The discrepancy
c a nb er e s o l v e db ys e t t i n gt h en u m b e ro ft e s t e df r a g -
ments per domain to, for example, 10, and by uniformly
using for all domains the above experimentally deter-
mined average values of 0.75 and 0.52 for p(D) and p(S),
respectively. As a result, 240 fragments are produced,
corresponding to 24 domains, of which 6 do not yield
any soluble fragment, since p(D) = 0.75. Since p(S) =
0.52, 124.8 fragments are soluble. These soluble frag-
ments are uniformly distributed among the 18 domains,
and thus 6.93 (7) fragments per domain out of 10 frag-
ments are soluble, which yields 0.693 for p(S|D). Using
Eq. 3, p(D) = 0.52/0.693 = 0.75, and thus p(D) PN =
0.75 * {1 - (1 - 0.693)
10 = 0.75, which is equal, within
rounding error, to the experimentally determined value
of 0.75 (18 domains out of 24).
Table 1 Estimated model parameters
DD
C ALL
S 0.52 ± 0.03 0.00 ± 0.00 0.52 ± 0.03
a
S
C 0.29 ± 0.03 0.19 ± 0.03 0.48 ± 0.03
b
ALL 0.81 ± 0.03
c 0.19 ± 0.03
d 1.00
a: p(S); b: p(S
C); c: p(D); d: p(D
C); S, S
C,D ,D
C: see the main text; ALL: All the
considered set; p(S ∩ D) (upper left cell): The probability of predicting a
soluble fragment of a soluble domain, similarly for the S
C ∩ D (middle left), S
∩ D
C (upper center), and S
C ∩ D
C (middle center); Standard deviations were
computed by bootstrapping, in which 1,000 sets of 215 randomly selected
fragments were sampled.
Figure 4 Soluble fragments for individual domains and cleavage sites. (a) Fractions of soluble fragments for individual domains. The
horizontal axis represents the ratio of soluble fragments to assessed fragments for each of the 24 analyzable domains. (b) Distribution of the
cleavage sites yielding soluble/insoluble fragments. The numbers of soluble and insoluble fragments are shown by white and dark gray bars,
respectively. The N- (upper panel) and C-terminal (bottom panel) cleavage sites of the fragments are classified into sites 0-4, as defined in Figure
2b.
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Page 5 of 9In the present experiment, 12 domains (221 frag-
ments) could not be analyzed because of failure to
express a fragment with a correct molecular weight, or
to assess the solubility, which obviously indicates that
the efficiency of our automated protein expression sys-
tem has room for improvement. These 12 domains can
be included in the analysis and will give lower (or
upper) limits by considering them as insoluble (or solu-
ble) domains. The inclusion yields 50% (18/36) and 25%
(111/436) for, respectively, the lower probability limit of
predicting the domain existence and that of predicting a
soluble fragment for 12 tested fragments, on average.
Similarly, some or all of the 6 domains that were con-
sidered insoluble in the above discussion might turn out
to be soluble if more fragments were tested.
Effect of the cleavage site on the solubility of the
dissected domain
T h ee f f e c to ft h ec l e a v a g es i t eo nt h es o l u b i l i t yo ft h e
dissected domain was also examined (Additional file 3).
All of the fragments corresponding to 6 domains
(KIAA0190.21-227, KIAA0309.483-717, KIAA1142.35-
97, KIAA1256.13-117, KIAA1416.55-202, and
KIAA1459.745-848) were soluble (all-soluble class);
while KIAA0067.1143-1295, KIAA0175.480-651,
KIAA0190.436-653, KIAA0277.120-349, KIAA0641.76-
352, and KIAA1338.180-406 were insoluble (all-insolu-
ble class), indicating a failed domain prediction. On the
other hand, the solubility of the remaining 12 domains
was dependent on the position of the cleavage site, and
both soluble and insoluble fragments were produced,
depending on slight shifts of the cleavage residue at
each of the N- and C- domain terminal ends (soluble
+insoluble class). The effects of the cleavage site within
the window were also examined. Except for site 4,
which corresponded to either the N or C protein termi-
nus, no differences in the yields of soluble fragments
were observed (Figure 4b). Note that the small number
of cleavage at site 4 simply results from the fact that not
all domains were located at the N or C protein
terminus.
Optimum fragment number per domain
Let us use our model to analyze protein dissection
experiments with different settings. Since p(D) is inde-
pendent of N, we can simplify Eq. 5, and examine
the normalized expected number of soluble domains,
edomain, instead of Edomain:
e
E
constant p
PN
Nr
domain
domain
D

 


, (8)
where PN can be computed with either Eq. 6 or 7,
since no noticeable difference will occur for practical
purposes (for most cases, within a few percent error; see
Figure 5). When no set-up cost is present (r = 0), edomain
is a monotone decreasing function of N (Figure 5a).
Thus, one fragment per predicted domain will optimize
the number of soluble domains (Noptimum = 1). This is
analytically demonstrated by showing that Noptimum is
the solution of a transcendental equation with a unique
solution (A mere exception occurs for f =1w h e nt h e
single copy per fragment model is used; Figure 5a and
Additional file 1).
Set-up costs are typically generated by the purchase of
new chemicals associated with the examination of a new
domain, and may, for example include the clone’sc o s t ,
from which the domain fragments are prepared by PCR.
Large r values may occur in a genetic screening-type
experiment, where the cost of assessing a new fragment
is small as compared to that of starting a new experi-
ment with a new domain. For r >0 ,edomain is not a
monotone decreasing function of N, but reaches a maxi-
mum at N = Noptimum (Figure 5b). The value of Noptimum
increases for increasing values of r (Figure 5b).
As an example, using the values derived from our pilot
experiment [p(S|D) = 0.63 (= f/F)] and assuming that
r = 10, we find that testing three fragments per predicted
domain would yield more soluble domains than just one,
for the same total cost (Figure 5b). Note that, as
r increases, the peak broadens and the maximum edomain
value, edomain (Noptimum), becomes smaller (Figure 5b).
Thus, in practical terms, the edomain dependence on N is
small for large r and it becomes less important to accu-
rately determine Noptimum.F i n a l l y ,w en o t et h a ti nE q .6
(multiple copy model), edomain depends on the ratio of
f and F, which is the probability of finding the correct
cleavage sites, but it does not depend directly on F alone,
which is the total number of possible cleavage sites. The
direct dependency on F alone is also minimal when the
single copy model (Eq. 7) is used (Figure 5b).
Insight into a wide range of experimental settings can
be obtained by analyzing the behavior of Noptimum for
several values of p(S|D) and r (Figure 5c). For example,
we find that Noptimum increases with decreasing values
of p(S|D), which is intuitively sensible, since a smaller
p(S|D) requires a larger number of trials for finding the
termini residues that yield a soluble domain fragment.
Noptimum is between 1 and 4 for r = 1 and a broad range
of p(S|D) > 0.1, which covers most experimental settings
including our pilot experiment using Kazusa sequences.
A p(S|D) > 0.1 would also cover typical domain predic-
tion tools such as Armadillo prediction, which has a
p(S|D) value estimated by cross validation method
between 0.3 and 0.5 [19]. Finally, for a typical value of r
= 10 and p(S|D) > 0.5, Noptimum is between 1 and 3; and
for p(S|D) = 0.63, Noptimum is 7 fragments, even for
r = 1,000 (i.e., a very large set-up cost).
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We have presented a novel mathematical formulation
for optimizing large-scale p r o t e i nd o m a i np r o d u c t i o n
experiments. Our model demonstrated that the testing
of one to seven fragments per domain will fit most high
throughput protein domain production experiments.
The probabilistic approach presented here is not limited
to protein domain production, and it can be readily
modified and applied for designing various types of
large-scale mutational analyses or screening libraries.
Methods
Computational protein dissection
Domains were computationally predicted from 2,032
Kazusa HUGE [21] protein sequences (KIAA0001-
KIAA2033), using ProteoMix [22], an integrated protein
sequence analysis system. The ProteoMix analysis
included PASS [23] for domain predictions, and DLiP [24]
and DLP [13,25] for domain linker predictions. PASS ana-
lyses were performed with default parameters (E-value =
1e-7, Cut-off homologues = 10); DLP with default
(Threshold = 0.5, Cut-off = 0.5, Ignored terminal length =
0, Window = 19, Minimum difference = 0.05); and DLiP
with no BLAST option. The other tools were HMMTOP
[26] and MEMSAT [27] for trans-membrane region pre-
diction, and BLAST [28] for removing domains homolo-
gous to structurally known protein sequences derived
from the Protein Data Bank [29]. We obtained 269 puta-
tive domains according to the following rules: A putative
domain was identified when it was a PASS predicted
domain region whose boundary overlapped either with
one of the full-length protein termini, or with a domain
boundary predicted with either DLiP and DLP results
(predicted domain linker regions) within ± 25 residues.
We also required that the putative domain did not include
transmembrane regions, as predicted by HMMTOP or
MEMSAT with default parameters, to remove the inher-
ently insoluble domains; and putative domains with
sequence identities higher than 30% to PDB protein
sequences were also removed. Finally, we choose 27
domains by visually inspecting the consistency among the
prediction’st o o l s ,d o m a i n ’s, and domain linker’ss i z e s .
In addition, we completed this set with 9 domains pre-
dicted in one of the putative multi-domain protein
sequences that contained one of the above 27 domains.
This yielded 36 domains that were assessed experimen-
tally. For each of the 36 dissected domains, a maximum of
20 fragments per domain, resulting in a total of 436 frag-
ments, were designed by combining the results of
PASS, DLiP, and DLP, and our termini selection rule (see
Figure 2b). This resulted in a 30 residue N- or C- terminal
end window (corresponding to 900 fragments per domain)
on average, from which the termini residues were selected.
Figure 5 Dependence of edomain on N. edomain and Noptimum were
calculated for the multiple and single copy cases with, respectively,
Eq. 6 (solid lines) and Eq. 7 (symbols). (a) edomain is represented as a
function of N for p(S| D) = 1, 0.63, 0.3, and 0.1. The curve for the
special case of f =1[ p(S| D) = 0.0011] is shown in the inserted
panel, with vertical scale magnified 300 times. (b) Curves for r >0
and F = 16 and 900. edomain are shown for r = 0, 1, 5, 10, and 100
with p(S| D) = 0.63. Noptimum > 1 is clearly apparent. (c) Noptimum is
shown as a function of p(S| D) for r = 1, 10, 100, and 1,000. Noptimum
can be any positive number. Noptimum for the single copy case are
discrete in N (symbols), while those for the multiple copy case are
continuous (dotted lines). Discretization of the single copy model
(solid lines) caused a small discrepancy at the very edge of
switching a step of solutions.
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The cDNA clones for the selected 36 protein domains
(436 fragments) were kindly provided by Kazusa DNA
Research Institute (Kisaradsu, Japan). The corresponding
protein fragments were expressed using an E-coli based
cell-free system and were purified as described [30]. The
fragments were classified as soluble, insoluble, and not
applicable, according to an SDS-PAGE analysis of the
supernatant and precipitate fractions. The soluble frag-
ments were defined as the fragments that remained in
the supernatant after centrifugation. The fragments that
were present in the SDS-PAGE of the precipitate, but
absent from the supernatant after centrifugation, were
defined as insoluble fragments. All other fragments were
classified as not applicable, which included all kinds of
experimental obstacles, such as unsuccessful PCR,
wrong cDNA sequences, no expression or ambiguous
SDS-PAGE results.
Additional file 1: Additional methods. An extension for handling the
distribution of p(S|D) with the multiple copy model; Basic properties of
PN; Intuitive Derivation of PN for the single copy per fragment case;
Direct Derivation of PN for the single copy per fragment case using the
hypergeometric distribution.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2105-11-
113-S1.PDF]
Additional file 2: Calculator of the expected number of soluble
domains. A JavaScript program, implementing Eqs. 5-7.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2105-11-
113-S2.HTML]
Additional file 3: Figure S1: List of expressed domains. List of
expressed domains in our pilot example. Computationally dissected
protein domains and their experimentally assessed solubilities.
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